TGF—β/Smad通路成员Smad7在鼻内翻性乳头状瘤中的表达和意义(4)
[10] Pardali E，Goumans M J，Ten D P.Signaling by members of the TGF-β family in vascul ar morphogenesis and disease.[Review][98 refs][J].Trends in Cell Biology，2010，20(9)：556-567.
[11] Massagué J.TGFβ signalling in context[J].Nature Reviews Molecular Cell Biology，2012，13(10)：616-630.
[12] Moustakas A，Heldin C H.The regulation of TGFβ signal transduction[J].Development，2009，136(22)：3699.
[13] Torbenson M，Marinopoulos S，Dang D T，et al.Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor betaⅡ receptor immunolabeling[J].Human Pathology，2002，33(9)：871-876.
[14] Imamura T M，Takase M，Nishihara A，et al.Smad6 inhibits signaling by the TGF-β superfamily[J].Nature，1997，389(6651)：622-626.
[15] Nakao A，Afrakhte M，Morn A，et al.Identification of Smad7，a TGFbeta-inducible antagonist of TGF-beta signalling[J].Nature，1997，389(6651)：631-635.
[16] Inoue Y，Imamura T.Regulation of TGF-beta family signaling by E3 ubiquitin ligases[J].Cancer Science，2008，99(11)：2107-2112.
[17] Shi W，Sun C，He B，et al.GADD34-PP1c recruited by Smad7 dephosphorylates TGF-β typeⅠ receptor[J].Journal of Cell Biology，2004，164(2)：291-300.
[18] Fei S，Li X，Kai Y，et al.Expression of VEGF-D，SMAD4，and SMAD7 and Their Relationship with Lymphangiogenesis and Prognosis in Colon Cancer[J].Journal of Gastrointestinal Surgery，2016，20(12)：1-9.
[19] Katsuno Y，Lamouille S，Derynck R.TGF-β signaling and epithelial-mesenchymal transition in cancer progression[J].Current Opinion in Oncology，2013，25(1)：76-84.
[20] Yamashita Y，Uehara T，Hasegawa M，et al.Squamous cell carcinoma antigen as a diagnostic marker of nasal inverted papilloma[J].American Journal of Rhinology & Allergy，2016，30(2)：122.
(收稿日期：2017-11-09) (本文編辑：张爽), http://www.100md.com(刘妙铮 赵昌通 张爱华)
[11] Massagué J.TGFβ signalling in context[J].Nature Reviews Molecular Cell Biology，2012，13(10)：616-630.
[12] Moustakas A，Heldin C H.The regulation of TGFβ signal transduction[J].Development，2009，136(22)：3699.
[13] Torbenson M，Marinopoulos S，Dang D T，et al.Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor betaⅡ receptor immunolabeling[J].Human Pathology，2002，33(9)：871-876.
[14] Imamura T M，Takase M，Nishihara A，et al.Smad6 inhibits signaling by the TGF-β superfamily[J].Nature，1997，389(6651)：622-626.
[15] Nakao A，Afrakhte M，Morn A，et al.Identification of Smad7，a TGFbeta-inducible antagonist of TGF-beta signalling[J].Nature，1997，389(6651)：631-635.
[16] Inoue Y，Imamura T.Regulation of TGF-beta family signaling by E3 ubiquitin ligases[J].Cancer Science，2008，99(11)：2107-2112.
[17] Shi W，Sun C，He B，et al.GADD34-PP1c recruited by Smad7 dephosphorylates TGF-β typeⅠ receptor[J].Journal of Cell Biology，2004，164(2)：291-300.
[18] Fei S，Li X，Kai Y，et al.Expression of VEGF-D，SMAD4，and SMAD7 and Their Relationship with Lymphangiogenesis and Prognosis in Colon Cancer[J].Journal of Gastrointestinal Surgery，2016，20(12)：1-9.
[19] Katsuno Y，Lamouille S，Derynck R.TGF-β signaling and epithelial-mesenchymal transition in cancer progression[J].Current Opinion in Oncology，2013，25(1)：76-84.
[20] Yamashita Y，Uehara T，Hasegawa M，et al.Squamous cell carcinoma antigen as a diagnostic marker of nasal inverted papilloma[J].American Journal of Rhinology & Allergy，2016，30(2)：122.
(收稿日期：2017-11-09) (本文編辑：张爽), http://www.100md.com(刘妙铮 赵昌通 张爱华)